Nicotine Édulcoré À L'acésulfame Potassique Et Au Sucralose Perrigo France

Nicotine, the active ingredient in Nicotine Édulcoré À L'acésulfame Potassique Et Au Sucralose Perrigo France, is a nicotinic receptor agonist presented as an oral sweetened formulation for oral use. It is employed to aid adults who wish to stop using tobacco products by reducing cravings and withdrawal symptoms.

GNH USA supplies Nicotine Édulcoré À L'acésulfame Potassique Et Au Sucralose Perrigo France as a licensed, GDP‑compliant international pharmaceutical supplier serving pharmacies and clinics worldwide.

Nicotine acts on nicotinic acetylcholine receptors to support smoking cessation and related tobacco‑dependence management.

- Smoking cessation: helps reduce cravings and withdrawal symptoms in adults attempting to quit tobacco. - Tobacco dependence: assists in managing nicotine withdrawal during a quit attempt. - Relapse prevention: provides a controlled nicotine source to lower the risk of returning to smoking.

Nicotine may cause a range of adverse reactions, most of which are mild and transient.

Common Side Effects: - Nausea: mild to moderate stomach upset. - Headache: transient tension‑type headache. - Dizziness: brief episodes of light‑headedness. - Insomnia: difficulty falling or staying asleep. - Gastrointestinal discomfort: abdominal cramping or loose stools. - Mouth irritation: tingling or soreness in the oral cavity.

Serious or Rare Side Effects: - Cardiovascular events: palpitations, increased heart rate, or hypertension. - Severe allergic reaction: rash, itching, swelling, or anaphylaxis. - Seizures: rare occurrence, especially with high nicotine exposure. - Arrhythmia: irregular heart rhythm. - Hypotension: sudden drop in blood pressure. - Respiratory depression: difficulty breathing in extreme cases.

When considering nicotine oral therapy, several safety measures should be observed.

- Cardiovascular assessment: evaluate heart rate and blood pressure before initiating therapy. - Dependence monitoring: watch for signs of new nicotine dependence or overuse. - Concomitant nicotine products: avoid using multiple nicotine replacement products simultaneously. - Pregnancy and lactation: safety not established; use only if benefit outweighs risk. - Drug interactions: review patient medication list for potential interactions. - Store at ambient temperature: keep below 25 °C in the original container, protect from moisture and direct sunlight.

Nicotine can interact with other medicines, altering its effects or increasing risk.

Major Interactions (Avoid): - Other nicotine replacement products: combined use may lead to nicotine overdose. - Monoamine oxidase inhibitors (MAOIs): may increase risk of hypertensive crisis. - Bupropion: concurrent use can raise seizure risk.

Moderate Interactions (Monitor Closely): - Cimetidine: may reduce nicotine clearance, raising plasma levels. - Beta‑blockers: nicotine‑induced tachycardia may counteract antihypertensive effect. - Oral contraceptives: nicotine may enhance metabolism, reducing contraceptive efficacy.